AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript August 10, 2023

AcelRx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.53.

Operator: Welcome to the AcelRx Second Quarter 2023 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of AcelRx’s website at www.acelrx.com. This call is the property of AcelRx, and any recording, reproduction or transmission of...